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We are grateful for the insightful comments received in response to our systematic review of metrics and evaluation tools for patient, public, consumer, and 
community (P2C2) engagement in healthcare organization- 
and system-level decision-making.1 Given their breadth and 
depth, it would be impossible to reply to every detail in this 
brief response. Here we describe areas of broad agreement 
as well as each comment’s important unique insights, with 
the hope that doing so will motivate scientific progress in 
enhancing P2C2 engagement.  
All five commentaries emphasize that any evaluation of 
P2C2 engagement should be guided by its fundamental goals 
or underlying theory.2-6 While we took an inductive approach 
in this review, we wholeheartedly agree, and our own earlier 
work reflects that.7 However, we bring to attention that our 
more recent research within a general patient population 
regarding their perspectives on patient representation. This 
research indicates that patients are just as concerned about 
“who” their representatives are and how they can interact 
with them as they are about the “why” of engagement 
[V. Dukhanin, S. Feeser, S. A. Berkowitz, M. DeCamp, 
unpublished materials].8 The implications of this deserve 
further study. 
In addition, all five commentaries rightly point out that 
incorporating studies from other engagement contexts (for 
example, health research or public health) could have changed 
our results or informed our discussion of P2C2 engagement 
in organization-, community-, and system-level healthcare 
decision-making. We acknowledge this limitation, done for 
the sake of mythological rigor, and agree regarding the need 
for those working in engagement to reach across engagement 
contexts. 
Sofaer helpfully reframes our taxonomy into a logic 
model that is attentive to realistic timelines and the stage 
of maturation of a particular healthcare organization or 
engagement strategy.2 We find this reframing incredibly 
helpful and hope that others will also. Sofaer also asks a 
fundamental question about engagement: Is engagement 
important in and of itself, or must it be justified by traditional 
outcomes, such as healthcare quality or costs? An ethical 
approach to engagement would likely argue that something of 
value would be lost, if we thought engagement were justified 
only by these traditional outcomes, but this question requires 
further critical analysis. Finally, Sofaer reminds us not to 
confuse failures of practice with failures of theory. We ought 
not to give up on efforts to purpose meaningful engagement 
simply because at present P2C2 engagement demonstrates far 
more of the former. 
Like Sofaer, Boivin suggests re-structuring of the taxonomy 
into structures, processes and outcomes and recommends 
adapting it to different P2C2 engagement methods (for 
example, focus groups versus surveys versus a patient-
clinician pair co-leading a project).3 Boivin also emphasizes 
the need for greater collaboration among engagement 
practitioners and the scientists who study it. We agree. In 
fact, in our experience conducting research with healthcare 
organizations, the act of research has the potential to 
improve engagement practice by simultaneously informing 
engagement initiatives at the organization studied. This is an 
argument for more research in this area. While perhaps not 
Boivin’s own view, we refrain from equating P2C2 engagement 
that lacks evidence of outcomes as purely “tokenistic.” Some 
process metrics, such as P2C2 representatives’ independence 
in decision-making or assurance of follow-up commitment to 
translate recommendations into action, represent real control 
over engagement and may be just as important as outcomes. 
Rahimi and colleagues provided a very useful supplement 
to our review by evaluating the psychometric properties of the 
identified P2C2 engagement tools.4 This work is exceptionally 
helpful. Moreover, the invocation to involve broader 
stakeholders, importantly patient and public representatives, 
in developing a “consensually agreed structured taxonomy” 
cannot be overemphasized. One idea for future research 
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would be to involve patients and public representatives in 
prioritizing elements of the taxonomy to develop a smaller 
number of core metrics tailored to specific contexts. 
Berger asks us to consider the connection between 
organizational- or system-level engagement and the 
engagement of individual patients with their clinicians 
and their healthcare.5 Whether one of the goals of P2C2 
engagement at the organizational- or system-level should be 
to affect directly individual-level patient engagement may be 
debated. If this were a goal, it would certainly have implications 
for the metrics one would use to evaluate P2C2 engagement, 
and metrics related to individual-level engagement did not 
feature prominently in our review. More research is required 
to address this question. 
Danis introduces an important additional dimension to 
P2C2 engagement evaluation: its timing.6 This did not arise 
in our review, but it is an important addition, and Danis is 
correct in noting that the results of any evaluation can be 
affected by when either the evaluation or the engagement 
itself occurs. In addition, the need to consider the political 
context of any engagement is critically important; if significant 
parts of healthcare organizations’ goals are determined by 
policy requirements, then the potential of P2C2 engagement 
participants to exert control and influence may be limited. 
In our view, this is an argument for engaging public in the 
creation of these policies. 
In summary, the vibrant discussion motivated by our 
systematic review is exactly what it is needed to generate 
and maintain momentum that will ensure successes of both 
theory and practice related to incorporating the needs, values, 
and preferences of patients, the public, consumers, and 
communities into healthcare delivery. 
Ethical issues 
Not applicable.
Competing interests 
Authors declare that they have no competing interests. 
Authors’ contributions 
Both authors contributed equally to the design of the manuscript, its drafting 
and editing for critical intellectual content, and its final approval for publication.
Authors’ affiliations
1Department of Health Policy and Management, Johns Hopkins Bloomberg 
School of Public Health, Baltimore, MD, USA. 2Johns Hopkins Berman Institute 
of Bioethics, Baltimore, MD, USA. 3Center for Bioethics and Humanities and 
Division of General Internal Medicine, University of Colorado, Denver, CO, USA.
References
1. Dukhanin V, Topazian R, DeCamp M. Metrics and evaluation tools 
for patient engagement in healthcare organization- and system-level 
decision-making: a systematic review. Int J Health Policy Manag. 
2018;7(10):889-903. doi:10.15171/ijhpm.2018.43
2. Sofaer S. Using the taxonomy and the metrics: what to study 
when and why: Comment on “Metrics and evaluation tools for 
patient engagement in healthcare organization- and system-level 
decision-making: a systematic review.”   Int J Health Policy Manag. 
2018;8(1):51-54. doi:10.15171/ijhpm.2018.99
3. Boivin A. From craft to reflective art and science: Comment on 
“Metrics and evaluation tools for patient engagement in healthcare 
organization- and system-level decision-making: a systematic 
review.” Int J Health Policy Manag. 2018;8(2):124-127. doi:10.15171/
ijhpm.2018.108
4. Abbasgholizadeh Rahimi S, Zomahoun HTV, Légaré F. Patient 
engagement and its evaluation tools – current challenges and 
future directions: Comment on “Metrics and evaluation tools for 
patient engagement in healthcare organization- and system-level 
decision-making: a systematic review.” Int J Health Policy Manag. 
2019;8(6):378-380. doi:10.15171/IJHPM.2019.16
5. Danis M. Delving into the details of evaluating public engagement 
initiatives: Comment on “Metrics and evaluation tools for patient 
engagement in healthcare organization- and system-level 
decision-making: a systematic review.”  Int J Health Policy Manag. 
2019;8(4):247-249. doi:10.15171/ijhpm.2018.126
6. Berger Z. Metrics of patient, public, consumer, and community 
engagement in healthcare systems: how should we define 
engagement, what are we measuring, and does it matter for 
patient care? Comment on “Metrics and evaluation tools for 
patient engagement in healthcare organization- and system-level 
decision-making: a systematic review.”  Int J Health Policy Manag. 
2018;8(1):49-50. doi:10.15171/IJHPM.2018.94
7. DeCamp M, Sugarman J, Berkowitz SA. Meaningfully engaging 
patients in ACO decision making. Am J Accountable Care. 
2015;3(2):30-33.
8. DeCamp M, Dukhanin V, Hebert LC, Himmelrich S, Feeser S, 
Berkowitz SA. Patients’ views about patient engagement and 
representation in health care governance. J Healthc Manag. In 
Press.
